Patents Assigned to Otago Innovation Limited
  • Publication number: 20130316378
    Abstract: The invention provides methods for predicting, diagnosing or monitoring acute cardiac disorders, cardiac transplant rejection, or distinguishing acute cardiac disorders from pulmonary disorders, by measuring BNP signal peptide levels in a sample taken from a subject shortly after onset of, or presentation with the disorder or transplant rejection.
    Type: Application
    Filed: April 15, 2013
    Publication date: November 28, 2013
    Applicant: OTAGO INNOVATION LIMITED
    Inventors: Christopher Joseph PEMBERTON, Arthur Mark RICHARDS, Michael Gary NICHOLLS, Timothy Grant YANDLE
  • Patent number: 8507209
    Abstract: The invention provides binding agents and assays for ghrelin signal peptide. The agents and assays are useful in methods for predicting, diagnosing, assessing or monitoring acute cardiac disorders, glucose handling disorders and diabetes in a subject. Also provided are nucleotides, polypeptides, and kits useful in the methods of the invention.
    Type: Grant
    Filed: March 12, 2009
    Date of Patent: August 13, 2013
    Assignee: Otago Innovation Limited
    Inventors: Christopher Joseph Pemberton, Arthur Mark Richards, Michael Gary Nicholls, Timothy Grant Yandle
  • Publication number: 20130072431
    Abstract: Compounds and compositions comprising a B-type natriuretic signal peptide fragment agent, and methods of use thereof, are provided for the treatment or prevention of cardiovascular diseases, disorders, and conditions.
    Type: Application
    Filed: August 17, 2012
    Publication date: March 21, 2013
    Applicant: Otago Innovation Limited
    Inventors: Christopher Joseph PEMBERTON, Arthur Mark Richards, Christopher John Charles, Maithri Siriwardena
  • Patent number: 8389236
    Abstract: The invention relates to a translational recoding reporter construct comprising: a first fluorescent protein coding sequence; a second fluorescent protein coding sequence encoding a fluorescent protein different from the first fluorescent protein; and a linker sequence interposed between the first and second fluorescent protein coding sequence; wherein the first fluorescent protein coding sequence and the second fluorescent protein coding sequence are out-of-frame with respect to each other but are co-expressed as a single fusion polypeptide upon recoding. The invention also relates to methods of use of the construct in screening modulators of recoding.
    Type: Grant
    Filed: August 30, 2006
    Date of Patent: March 5, 2013
    Assignee: Otago Innovation Limited
    Inventors: Tony Stuart Cardno, Warren Perry Tate
  • Patent number: 8298772
    Abstract: The invention provides methods for predicting, diagnosing or monitoring acute cardiac disorders, cardiac transplant rejection, or distinguishing acute cardiac disorders from pulmonary disorders, by measuring BNP signal peptide levels in a sample taken from a subject shortly after onset of, or presentation with the disorder or transplant rejection.
    Type: Grant
    Filed: March 6, 2009
    Date of Patent: October 30, 2012
    Assignee: Otago Innovation Limited
    Inventors: Christopher Joseph Pemberton, Arthur Mark Richards, Michael Gary Nicholls, Timothy Grant Yandle
  • Publication number: 20120041440
    Abstract: An intra-oral stabilisation device has an upper tray (101), a lower tray a lower tray (201), and at least two spacers (217) to provide a spacing between the anterior portions of the upper and lower trays. Spacers (217) provide a spacing between anterior portions of the trays, and are positioned between corresponding posterior portions of the trays. Engagement features (301) are provided for engaging undersides of the posterior portions of the upper tray with upper sides of the posterior potions of the lower tray, and minimise lateral movement of the trays relative to one another once the trays are engaged with one another. In an alternative embodiment, the device may have only the lower tray, and may have a locator (219) for stabilising an endotracheal tube 401 relative to the lower tray. The upper or lower tray can be used to stabilise fracture segments of a fractured jaw.
    Type: Application
    Filed: February 3, 2010
    Publication date: February 16, 2012
    Applicant: OTAGO INNOVATION LIMITED
    Inventors: Darryl Chan Tong, John Neil Waddell, Murray Edward Fenton
  • Publication number: 20110287010
    Abstract: The present invention relates to methods of detecting, monitoring and treating prostate cancer (PRC) OR prostatic intraepithelial neoplasia (PIN) or a predisposition to same. Provided for use in the methods is a novel cancer marker, PSPU43, as well as bioassays and kits.
    Type: Application
    Filed: June 7, 2007
    Publication date: November 24, 2011
    Applicant: Otago Innovation Limited
    Inventors: Stephen John Assinder, Jo-Ann Stanton
  • Patent number: 7919255
    Abstract: A means of measuring and monitoring skeletal growth rate using a plasma analyte, amino-terminal C-type natriuretic peptide (NT-CNP). Plasma NT-CNP concentrations reflect the potential for further growth of the immature skeleton. Measurement of plasma NT-CNP in a subject, when related to the mean of an appropriate age and gender matched set of control subjects, provides an index of the severity of a growth disorder not otherwise available and facilitates diagnosis in children with undetected osteo-chondrodysplasias or other intrinsic disorders of the growth plate. The invention also provides a means of detecting and monitoring potentially harmful effects of drugs and other factors on skeletal growth long before they are evident using current methods in clinical practice.
    Type: Grant
    Filed: June 17, 2004
    Date of Patent: April 5, 2011
    Assignee: Otago Innovation Limited
    Inventors: Timothy Charles Ramsey Prickett, Eric Arnold Espiner, Arthur Mark Richards, Timothy Grant Yandle, Michael Gary Nicholls
  • Publication number: 20090304675
    Abstract: This invention relates to methods for modulating neuronal cell death or impairment, and methods for the treatment, prevention, and/or amelioration of symptoms of one or more conditions or diseases in a mammal caused by neuronal cell death or dysfunction.
    Type: Application
    Filed: October 26, 2006
    Publication date: December 10, 2009
    Applicant: OTAGO INNOVATION LIMITED C/-TD SCOTT & CO.
    Inventors: Ian Stuart McLennan, Kyoko Koishi, Pei-Yu Wang
  • Publication number: 20080193549
    Abstract: Oil obtained from the liver of hoki fish is a potent inhibitor of angiogenesis and inflammation, and a modulator of the immune system. Compositions containing hoki liver oil, or fractions thereof, are useful for treating diseases or disorders associated with angiogenesis and inflammation. Certain oil fractions are potent stimulants of the immune system whereas other fractions are potent suppressants of the immune system.
    Type: Application
    Filed: July 5, 2005
    Publication date: August 14, 2008
    Applicant: Otago Innovation Limited
    Inventor: Paul Frank Davis
  • Publication number: 20080020070
    Abstract: The use of a citrus fruit skin extract for promoting angiogenesis, or treating a disease or disorder where it is desirable to promote angiogenesis. Such diseases include coronary heart disease, stroke, or ulcers. A composition comprising an extract of citrus fruit skin suitable for use in promoting angiogenesis, or treating a disease or disorder where it is desirable to promote angiogenesis. A process for preparing a citrus fruit skin extract. The citrus fruit may be grapefruit, orange, lemon, lime, mandarin, tangelo, tangerine or uglis, preferably grapefruit (Citrus paradisii).
    Type: Application
    Filed: April 29, 2005
    Publication date: January 24, 2008
    Applicants: Industrial Research Limited, University of Otago, Otago Innovation Limited
    Inventors: Paul Davis, Lai Foo
  • Patent number: 7173706
    Abstract: An apparatus for remote gas sensing comprising a light source, a photodetector, a gas cell containing gas or a zone through which the gas passes and through which light from the light source passes and is reflected back to the photodetector, wherein the light source, photodetector and gas cell are connected by a single polarization preserving optical fiber through which light from the light source passes to the gas cell, which light reflected back from the cell passes back through the optical fiber with a different polarization to that to the light transmitted by the light source. In one form the gas cell comprises a resonant optical cavity.
    Type: Grant
    Filed: September 12, 2003
    Date of Patent: February 6, 2007
    Assignee: Otago Innovation Limited
    Inventors: Andrew Wilson, Nicola van Leeuwen